← Back to Search

Cell Therapy

Intervention Group for Osteoarthritis (KICK-OA Trial)

N/A
Waitlist Available
Led By Daniel K White, PT, ScD, MSc
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change in pain of target knee from baseline to 3 weeks, and change in pain of target knee from baseline to 3 months.

Summary

This trial is testing whether an injection of autologous, nucleated cells can help improve symptoms for people with knee osteoarthritis.

Eligible Conditions
  • Osteoarthritis of the Knee

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change in pain of target knee from baseline to 3 weeks, and change in pain of target knee from baseline to 3 months.
This trial's timeline: 3 weeks for screening, Varies for treatment, and change in pain of target knee from baseline to 3 weeks, and change in pain of target knee from baseline to 3 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Physical Activity
Secondary study objectives
Function of Target Knee
Pain of Target Knee

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention GroupExperimental Treatment1 Intervention
Injection of Bone Marrow Concentrate (BMC)
Group II: Control GroupPlacebo Group1 Intervention
Injection of saline

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
161 Previous Clinical Trials
25,642 Total Patients Enrolled
6 Trials studying Osteoarthritis
438 Patients Enrolled for Osteoarthritis
Daniel K White, PT, ScD, MScPrincipal InvestigatorUniversity of Delaware
2 Previous Clinical Trials
168 Total Patients Enrolled
~0 spots leftby Nov 2025